Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Davorka Dusek"'
Autor:
Neven Papic, Leona Radmanic, Davorka Dusek, Ivan Kurelac, Snjezana Zidovec Lepej, Adriana Vince
Publikováno v:
Infectious Disease Reports, Vol 12, Iss 3, Pp 74-81 (2020)
Late presentation to care is the major obstacle to receiving treatment for chronic hepatitis C (CHC). Our aim was to analyze the prevalence and trends of late presenters (LP) at first consultations in Croatia during a 10-year period. This retrospecti
Externí odkaz:
https://doaj.org/article/5f3b79ea00b84fa7b2114835ca4e4983
Publikováno v:
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti. 63(5)
Molecular methods are a well-established part of routine diagnostic work-up in patients infected with hepatitis B virus (HBV) and hepatitis C virus (HCV). Confirmation of active viral replication in infected patients is based on detection and/or quan
Publikováno v:
Croatian medical journal. 45(1)
To assess the academic performance of students who transferred to the Zagreb School of Medicine from other three medical schools in Croatia.Academic performance of medical students who moved from Rijeka, Osijek, or Split University Medical Schools to
Autor:
Davorka Dušek, Adriana Vince, Ivan Kurelac, Neven Papić, Klaudija Višković, Peter Deplazes, Relja Beck
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 2, Pp 364-366 (2020)
Alveolar echinococcosis is a parasitic disease caused by the tapeworm larval stage of Echinococcus multilocularis. This zoonotic disease has not been known to occur in Croatia. We report a confirmed case of human alveolar echinococcosis in a patient
Externí odkaz:
https://doaj.org/article/3a975a098e2b4bad97393f19bfc976fe
Autor:
Neven Papić, Jelena Budimir, Ivan Kurelac, Davorka Dušek, Davor Jugović, Nina Krajcar, Adriana Vince
Publikováno v:
Acta Clinica Croatica, Vol 57., Iss 1., Pp 61-70 (2018)
The prevalence of chronic hepatitis C increases in elderly patients. The aims of this study were to identify the factors associated with hepatocellular carcinoma (HCC) and end-stage liver disease development and to evaluate the efficacy and safety of
Externí odkaz:
https://doaj.org/article/ae29109641994b2990500f2dd1c950e3